Acceleron Pharma (XLRN) News Today → What is Medicare Supplement Insurance? (From Tranzact) (Ad) Free xlrn Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineORBIMED CAPITAL GP II LLC's Net Worthbenzinga.com - February 27 at 3:47 PMXLRN Historical Datainvesting.com - October 20 at 10:08 AMBrexit Bargain Buys: 14 More Stocks Picked by Morgan Stanleythestreet.com - April 15 at 8:35 AMAstellas Pharma Increuters.com - March 17 at 6:17 AMAcceleron Corp Becomes a Digital Correspondent Bankfinance.yahoo.com - December 14 at 8:40 AMPharma Contract Sales Market Report 2022-2032finance.yahoo.com - November 30 at 8:26 PMMerck to buy Imago for $1.35 bln to broaden portfolio of blood disorder drugsreuters.com - November 21 at 12:55 PMCentre Piece Of Merck's $11.5B Acceleron Buyout Aces Late-Stage Cardiovascular Trialmsn.com - October 10 at 2:29 PMLiquidia slumps as United, MannKind get FDA nod for rival therapyseekingalpha.com - May 23 at 4:11 PM19 Charts to Calm Your Recession Fearsthestreet.com - January 20 at 10:48 PMXLRN May 2022 140.000 putfinance.yahoo.com - December 22 at 10:04 PMMerck Closes Biggest Biotech Deal of the Yearfinance.yahoo.com - November 22 at 2:09 PMMerck announces completion of Acceleron Pharma acquisitionseekingalpha.com - November 22 at 7:52 AMmarketbeat.com - November 22 at 6:04 AMMerck's (NYSE:MRK) Balance Sheet Can Easily Handle Acquisitions like Acceleron Pharma (NASDAQ: XLRN)nasdaq.com - November 21 at 8:45 AMAvoro Capital Urges Acceleron Shareholders Not to Tender Into Merck’s Inadequate Offerapnews.com - November 17 at 6:32 PMNotable Wednesday Option Activity: XLRN, LOW, ZGNXnasdaq.com - November 17 at 6:32 PMMerck Announces Expiration of Hart-Scott-Rodino Act Waiting Period and Extension of Tender Offer to Acquire Acceleron Pharma Inc.finance.yahoo.com - November 17 at 8:31 AMMerck says HSR waiting period for Acceleron Pharma deal expiresseekingalpha.com - November 17 at 7:23 AMAvoro Capital Advisors LLC Buys Acceleron Pharma Inc, Apellis Pharmaceuticals Inc, Aadi ...gurufocus.com - November 15 at 3:06 PMWestern Standard LLC Buys IHS Markit, Acceleron Pharma Inc, Marlin Business Services Corp, ...gurufocus.com - November 15 at 3:05 PMSome Acceleron Investors Want a Better Deal From Merckfinance.yahoo.com - November 12 at 6:01 PMIs Merck's Planned Acquisition of Acceleron in Trouble?msn.com - November 12 at 7:38 AMAvoro Capital Releases Presentation Detailing Why Acceleron Shareholders Should Not Tender Into Merck’s Inadequate Offerfinance.yahoo.com - November 9 at 8:33 PMAcceleron: Q3 Earnings Snapshotchron.com - November 4 at 9:01 PMAcceleron Reports Third Quarter 2021 Financial Resultsfinance.yahoo.com - November 4 at 9:01 PMWhy Earnings Season Could Be Great for Acceleron Pharma (XLRN)finance.yahoo.com - November 3 at 2:58 PMNOTICE - IMPORTANT SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith Reminds Investors of Investigations Related to the Following Companies: Acceleron Pharma Inc. (Nasdaq - XLRN), Kraton Corporation (NYSE - KRA), Dawson Geophysical Company (Nasdaq – DWSN)finance.yahoo.com - November 2 at 6:08 PMFarallon Capital Opposes Terms of Merck’s Acceleron Takeoverfinance.yahoo.com - November 2 at 1:01 PMMerck Pushes Acceleron Buyout By Refiling For Antitrust Reviewfinance.yahoo.com - November 1 at 8:49 PMMerck to Refile Notification of Acceleron Merger Deal, Extending Deadline for Shareholdersfinance.yahoo.com - October 30 at 3:28 PMAvoro Capital Slams Merck's $11.5B Acceleron Deallaw360.com - October 28 at 8:12 PMEarnings Preview: Acceleron Pharma (XLRN) Q3 Earnings Expected to Declinefinance.yahoo.com - October 28 at 8:12 PMSHAREHOLDER NOTICE: Brodsky & Smith Continues an Investigation of Acceleron Pharma Inc. (Nasdaq - XLRN)finance.yahoo.com - October 28 at 3:12 PMAvoro Capital Issues Open Letter to Fellow Acceleron Pharma Shareholdersfinance.yahoo.com - October 28 at 10:12 AMAcceleron Announces Third Quarter 2021 REBLOZYL® Net Salesfinance.yahoo.com - October 27 at 9:07 AMMerck (MRK) to Report Q3 Earnings: What's in the Cards?finance.yahoo.com - October 25 at 3:49 PMBristol-Myers Plans to Exit Acceleron Stake With Merck Dealfinance.yahoo.com - October 21 at 12:17 AMACCELERON PHARMA ALERT: Investors Should Contact Bragar Eagel & Squire, P.C. Over Tender Offer for XLRN Sharesfinance.yahoo.com - October 18 at 4:15 PM(XLRN): Johnson Fistel Investigates Proposed Sale of Acceleron Pharma; Is $180 a Fair Price?finance.yahoo.com - October 15 at 9:54 AMSHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Acceleron Pharma Inc. - XLRNfinance.yahoo.com - October 13 at 6:25 PMHolocene Advisors says Merck’s offer undervalues Acceleronfinancialpost.com - October 13 at 3:58 PMMerck Begins Tender Offer to Acquire Acceleron Pharma Inc.finance.yahoo.com - October 12 at 9:57 AM3 Reasons to Buy Merck Stock Right Nowfinance.yahoo.com - October 9 at 8:18 AMIs an Acquisition of Acceleron a Smart Move for Merck?msn.com - October 8 at 10:05 AMNOTICE - IMPORTANT SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith Reminds Investors of Investigations Related to the Following Companies: Acceleron Pharma Inc. (NASDAQ:XLRN), Sanderson Farms, Inc. (NASDAQ:SAFM), JMP Group LLC (NYSE:JMP)finance.yahoo.com - October 7 at 3:25 AMMERGER ALERT - TGP, XLRN, and VNE: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companiesfinance.yahoo.com - October 6 at 7:29 AMWhere Acceleron Pharma Stands With Analystsmarkets.businessinsider.com - October 4 at 2:27 PMWith Acceleron Acquisition Merck Stock Is Likely To See A Multiple Revisionforbes.com - October 4 at 12:13 PMACCELERON INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Acceleron Pharma Inc ...businesswire.com - October 2 at 6:26 PM Get Acceleron Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for XLRN and its competitors with MarketBeat's FREE daily newsletter. Email Address Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow. Click here for your free guide XLRN Media Mentions By Week XLRN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XLRN News Sentiment▼0.000.32▲Average Medical News Sentiment XLRN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XLRN Articles This Week▼00▲XLRN Articles Average Week Get Acceleron Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for XLRN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: RGEN News Today QGEN News Today NBIX News Today EXEL News Today PCVX News Today RVMD News Today HALO News Today CRSP News Today KRYS News Today IMVT News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XLRN) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyHe Is Giving Away BitcoinCrypto Swap ProfitsProtect Your Bank Account Before It’s Too LateWeiss RatingsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acceleron Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
